<DOC>
	<DOCNO>NCT00637429</DOCNO>
	<brief_summary>Human immunodeficiency virus/Hepatitis B virus ( HIV/HBV ) co-infections frequently observe due share route transmission , report figure indicate 6-9 % HIV-infected individual develop country chronically infected HBV . HIV infection impact natural progression HBV infection , increase level HBV replication risk liver-associated mortality . Liver diseases associate HBV affect antiviral drug use HIV infection ( toxic side effect ) , current immune function patient , improvement immune system bring control HIV infection , development resistance antiviral agent use hepatitis B HIV infection . Co-infection HBV increase risk hepatotoxicity individual receive highly active antiretroviral therapy ( HAART ) HIV infection . This study recruit patient co-infected HIV HBV , currently take commence HAART . The study cohort include HIV-HBV co-infected individual Alfred Hospital , Royal Melbourne Hospital high case load GP clinic refer Alfred Hospital . The aim study investigate chronic hepatitis B impact progression liver disease HIV-infected person receive HAART . This achieve 6 monthly assessment medical history , physical examination , blood marker liver disease hepatitis B activity completion questionnaires measure adherence alcohol use .</brief_summary>
	<brief_title>HIV-HBV Co-Infection Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Coinfection</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<criteria>18 year age old HIV positive 2 positive Hepatitis B surface antigen result 6 month apart provision informed consent unable provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>